Gabelli Funds LLC Clovis Oncology, Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.05 - $2.85 $2,100 - $5,700	-2,000 Reduced 1.77%	110,900 $132,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $1,260 - $5,920	-2,000 Reduced 1.74%	112,900 $203,000
Q1 2022 May 13, 2022	BUY	$1.43 - $3.14 $7,150 - $15,700	5,000 Added 4.55%	114,900 $232,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $20,299 - $29,000	5,000 Added 4.77%	109,900 $490,000
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $25,099 - $35,250	5,000 Added 5.01%	104,900 $608,000
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $265,512 - $570,768	-55,200 Reduced 35.59%	99,900 $701,000
Q4 2020 Feb 05, 2021	BUY	$4.13 - $6.41 $13,216 - $20,512	3,200 Added 2.11%	155,100 $744,000
Q3 2020 Nov 06, 2020	BUY	$4.82 - $7.72 $26,510 - $42,460	5,500 Added 3.76%	151,900 $886,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $9.69 $17,070 - $29,070	-3,000 Reduced 2.01%	146,400 $988,000
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $3,770 - $11,000	1,000 Added 0.67%	149,400 $950,000
Q3 2019 Nov 01, 2019	BUY	$3.93 - $15.35 $155,235 - $606,325	39,500 Added 36.27%	148,400 $583,000
Q2 2019 Aug 02, 2019	BUY	$12.81 - $25.67 $822,402 - $1.65 Million	64,200 Added 143.62%	108,900 $1.62 Million
Q1 2019 May 02, 2019	BUY	$17.66 - $30.28 $526,268 - $902,344	29,800 Added 200.0%	44,700 $1.11 Million
Q4 2018 Jan 30, 2019	BUY	$11.63 - $32.67 $93,040 - $261,360	8,000 Added 115.94%	14,900 $268,000
Q3 2018 Nov 02, 2018	BUY	$29.37 - $49.48 $44,055 - $74,220	1,500 Added 27.78%	6,900 $203,000
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $841,200 - $1.25 Million	-20,000 Reduced 78.74%	5,400 $246,000
Q1 2018 May 09, 2018	BUY	$50.12 - $67.72 $345,828 - $467,268	6,900 Added 37.3%	25,400 $1.34 Million
Q4 2017 Feb 02, 2018	BUY	$57.69 - $84.58 $178,839 - $262,198	3,100 Added 20.13%	18,500 $1.26 Million
Q3 2017 Nov 01, 2017	BUY	$67.17 - $84.81 $1.03 Million - $1.31 Million	15,400	15,400 $1.27 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account